We are a commercial stage pharmaceutical company focused on developing and delivering innovative new treatments that help improve the lives of people with rare and orphan diseases.
We are building an exciting portfolio of breakthrough, proprietary medicines by looking beyond the ordinary and recognising potential, where others see none.
A core belief at Amryt Pharma is that we operate on a foundation of responsibility, integrity and ethical practice. We aim to forge partnerships and collaborations that work for all. By listening to our stakeholders we create a clear path for our transformative medicines to reach those that need them.
Shore Capital and Corporate Limited
Shore Capital Stockbrokers Limited, Stifel Nicolaus Europe Limited and J & E Davy